Skip to content
Screener

Integra LifeSciences IART Asia Pacific — Total Revenues

Other geography segments

Europe
$42.57M-0.1%
Rest of World
$20.39M+7.5%

Similar metrics at other companies

Xerox Holdings Corporation logo
XRXAsia Pacific — Total Revenues
$58M+480%
EAF
EAFAsia Pacific — Total Revenues
$7.98M-44.6%
Accenture logo
ACNAsia Pacific — Total Revenues
$2.71B+7.0%
AMR
AMRZPacific — Total Revenues
$333.5M+5.9%
MetLife logo
METAsia — Total Revenues
$3.07B+5.9%
ESP
ESPRCollaboration revenue — Total Revenues
$36.71M+22.0%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.33B+38.0%
Enterprise value$3.08B+16.2%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Dollars in thousandsThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
United States$307,099$306,308$596,479$588,525
Europe42,57242,59482,53577,920
Asia Pacific48,69747,73293,90892,837
Rest of World20,39318,97137,75738,976
Total Revenues$418,761$415,605$810,679$798,258

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's asia pacific — total revenues?
Integra LifeSciences (IART) reported asia pacific — total revenues of $48.7M in Q2 2026.
How has Integra LifeSciences's asia pacific — total revenues changed year-over-year?
Integra LifeSciences's asia pacific — total revenues increased by 2.0% year-over-year, from $47.73M to $48.7M.
What is the long-term trend for Integra LifeSciences's asia pacific — total revenues?
Over 4 years (2021 to 2025), Integra LifeSciences's asia pacific — total revenues has grown at a 1.0% compound annual growth rate (CAGR), from $182.03M to $189.25M.
What does asia pacific — total revenues mean?
This metric represents the total net sales generated from products and services sold within the Asia Pacific geographic region. It serves as a key indicator of the company's market penetration, demand, and growth trajectory in these specific international markets. Tracking this revenue stream helps investors assess the effectiveness of regional sales strategies and the company's ability to compete against local and global medical device manufacturers.

Ask your AI about Integra LifeSciences's asia pacific — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude